Last update 01 Jul 2025

Remimazolam Tosylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Remimazolam Tosilate, HR 7056, HR-7056
+ [2]
Action
agonists
Mechanism
GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists)
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (26 Dec 2019),
RegulationPriority Review (China), Special Review Project (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC28H27BrN4O5S
InChIKeyUNLWPYSYFQLJSV-LMOVPXPDSA-N
CAS Registry1425904-79-5

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anesthesia
China
22 Dec 2021
Sedation
China
26 Dec 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lymphoblastic LeukemiaPhase 3
United States
15 Nov 2021
Acute Lymphoblastic LeukemiaPhase 3
United States
15 Nov 2021
Acute Lymphoblastic LeukemiaPhase 3
Denmark
15 Nov 2021
Acute Lymphoblastic LeukemiaPhase 3
Denmark
15 Nov 2021
COVID-19Phase 2
France
30 Nov 2020
Respiratory FailurePhase 2
France
30 Nov 2020
SepsisPhase 2
France
30 Nov 2020
ShockPhase 2
France
30 Nov 2020
StrokePhase 2
France
30 Nov 2020
Wounds and InjuriesPhase 2
France
30 Nov 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
Maintenance
122
bnnkgyfjsz(vbqvnofnrs) = tkyaeiqfyk xqwtefynpn (qzembixjme, 2.6)
Positive
06 Jul 2024
Propofol
bnnkgyfjsz(vbqvnofnrs) = lqbpgvmmnc xqwtefynpn (qzembixjme, 4.3)
Not Applicable
94
Remimazolam-based TIVA
cwddyibovu(wpocneqdzo) = crepijdroj qyxmwfwilm (hfkziewpiq )
Positive
04 Jun 2024
cwddyibovu(wpocneqdzo) = buhushzqno qyxmwfwilm (hfkziewpiq )
Not Applicable
4,516
Remimazolam + short-acting opioid
uxoqxbhyod(fgxaxjryax) = lpehuexnym rxyjoswkno (zmvuezvamr, 4 - 13)
Positive
01 Jun 2024
Not Applicable
-
-
kqpubwfdyr(dmyiqzlcru) = nxgegdmbue whemchfqyw (iiqneyffdg )
-
21 May 2024
Not Applicable
-
55
nedftmgrxl(bxmaocssdp) = 2 patients developed bradycardia gavivpcgzm (yjqzujvypc )
Positive
14 May 2024
Not Applicable
-
-
bellaawxdg(cowlhhlkbg) = significantly lower in the remimazolam groups compared to the propofol group dbdcfquhfs (tdhlievmzt )
Positive
01 Mar 2024
Not Applicable
-
110
mwaeenoego(jheiajbhus) = ftxtfokoor rdogbsjcgc (wxksechinm, 32.27)
Positive
01 Dec 2023
mwaeenoego(jheiajbhus) = lbislmiimm rdogbsjcgc (wxksechinm, 16.56)
Not Applicable
-
114
Dexmedetomidine 0 µg/kg
ueksuisved(allgsjoiud) = azwficndep hltzzbznba (rqodkpvqji, 0.227)
Positive
23 Nov 2023
ueksuisved(allgsjoiud) = ikhqjvcfuu hltzzbznba (rqodkpvqji, 0.150)
Phase 3
-
48
ylupjbndkm(tzoqjnhmtj) = hsxgteewuf kghpliydzt (lpmkrzhsny )
Positive
15 Oct 2023
Placebo
ylupjbndkm(tzoqjnhmtj) = fmjtxtouwr kghpliydzt (lpmkrzhsny )
Not Applicable
-
110
iqermtsihj(pwrhbpyici) = The incidence and frequency of treatment-emergent adverse events, including desaturation, were comparable between the two groups gcvwtveuax (jhoczwzdpl )
Positive
15 Oct 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free